Maxair and Breastfeeding
While there have been no studies conducted on Maxair and breastfeeding, it is believed that the medicine is probably safe for most women who are breastfeeding. Make sure to talk with your healthcare provider about the risks and benefits of using the medication while nursing. If you are using Maxair and breastfeeding, you should watch for side effects in your baby.
It is not known if Maxair® (pirbuterol acetate) is passed through breast milk. Because of the potentially serious side effects that could occur in the nursing infant, the manufacturer of Maxair recommends that healthcare providers consider the possible risks and benefits before recommending Maxair to a woman who is breastfeeding. Therefore, if you are breastfeeding or thinking of breastfeeding and have been prescribed Maxair, make sure to let your healthcare provider know.
Maxair inhalers will not be made, dispensed, or sold in the United States in their current form after December 31, 2013. Maxair contains chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer. The U.S. Food and Drug Administration (FDA) has set this final date for the medication in order to comply with the Montreal Protocol on Substances That Deplete the Ozone Layer. The manufacturer of Maxair is working on a reformulated, CFC-free version, although it is not yet clear when that product will be available to consumers.
No research has been done to see if Maxair is passed through breast milk. However, it is thought that Maxair is probably safe for most women who are breastfeeding. If your healthcare provider recommends taking Maxair while breastfeeding, be sure to watch for any side effects in your child.